In a study using Sativex, a spray form of medication that contains both THC (delta-9-tetrahydrocannabinol) and cannabidiol, participants were monitored for intoxication. When used appropriately, even when subjects were allowed to increase the dose until they felt is was beneficial for neuropathic pain symptoms, it did not seem to change their cognitive function when tested.